Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans

被引:86
作者
Bonson, KR
Buckholtz, JW
Murphy, DL
机构
[1] Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, MD
[2] Laboratory of Clinical Science, National Institute of Mental Health, Building 10, Bethesda
关键词
LSD; hallucinogen; antidepressant; serotonin reuptake inhibitor; human studies;
D O I
10.1016/0893-133X(95)00145-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study investigates the possible interactions of antidepressant agents and hallucinogens in humans through structured interviews using a standardized questionnaire. Volunteer subjects recruited through announcements placed on the Internet or other sources were asked to describe the somatic, hallucinatory, and psychological effects of self-administered LSD prior to and during chronic administration of an antidepressant. Twenty-eight out of 32 subjects (88%) who had taken an antidepressant with inhibitory effects on serotonin (5-HT) reuptake (fluoxetine, paroxetine, sertraline, trazodone) for over 3 weeks had a subjective decrease or virtual elimination of their responses to LSD. An additional subject who had taken fluoxetine for only 1 week had an increased response to LSD. These data are in contrast to our previous study that reported increased responses to LSD during chronic administration of tricyclic antidepressants or lithium. Possible mechanisms of action for the effects from serotonergic antidepressants involve 5-HT2 and 5-HT1A receptors, changes in extracellular brain serotonin concentrations, and changes in brain catecholamine systems.
引用
收藏
页码:425 / 436
页数:12
相关论文
共 97 条
  • [1] AGHAJANIAN GK, 1975, PSYCHOPHARMACOL COMM, V1, P619
  • [2] CHARACTERIZATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES INDUCED BY 5-HT1 AND 5-HT2 AGONISTS IN RATS
    ARNT, J
    [J]. PHARMACOLOGY & TOXICOLOGY, 1989, 64 (02): : 165 - 172
  • [3] RAPID DOWN REGULATION OF BETA-ADRENOCEPTORS BY CO-ADMINISTRATION OF DESIPRAMINE AND FLUOXETINE
    BARON, BM
    OGDEN, AM
    SIEGEL, BW
    STEGEMAN, J
    URSILLO, RC
    DUDLEY, MW
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 154 (02) : 125 - 134
  • [4] PH-DEPENDENT MODULATION OF AGONIST INTERACTIONS WITH [KETANSERIN-H-3-LABELED S-2 SEROTONIN RECEPTORS
    BATTAGLIA, G
    SHANNON, M
    BORGUNDVAAG, B
    TITELER, M
    [J]. LIFE SCIENCES, 1983, 33 (20) : 2011 - 2016
  • [5] FLUOXETINE - A REVIEW OF RECEPTOR AND FUNCTIONAL-EFFECTS AND THEIR CLINICAL IMPLICATIONS
    BEASLEY, CM
    MASICA, DN
    POTVIN, JH
    [J]. PSYCHOPHARMACOLOGY, 1992, 107 (01) : 1 - 10
  • [6] CHRONIC TREATMENT WITH FLUVOXAMINE INCREASES EXTRACELLULAR SEROTONIN IN FRONTAL-CORTEX BUT NOT IN RAPHE NUCLEI
    BEL, N
    ARTIGAS, F
    [J]. SYNAPSE, 1993, 15 (03) : 243 - 245
  • [7] MECHANISM AND MANAGEMENT OF IMPORTANT PSYCHOTHERAPEUTIC DRUG-INTERACTIONS
    BIRKHIMER, LJ
    DEVANE, CL
    MUNIZ, CE
    [J]. SOUTHERN MEDICAL JOURNAL, 1984, 77 (04) : 465 - 469
  • [8] BLIER P, 1983, J NEUROSCI, V3, P1270
  • [9] Bonson KR, 1996, BEHAV BRAIN RES, V73, P229
  • [10] SEROTONIN2 AGONIST ADMINISTRATION DOWN-REGULATES RAT-BRAIN SEROTONIN2 RECEPTORS
    BUCKHOLTZ, NS
    ZHOU, DF
    FREEDMAN, DX
    [J]. LIFE SCIENCES, 1988, 42 (24) : 2439 - 2445